Your Blood Work Looks Fine, But Your Genes Tell a Different Story.

Your MTHFR gene produces an enzyme that converts raw B vitamins (folate and B12) into their active forms. These active forms are essential for methylation, a process that happens millions of times per second in your cells. Methylation is how your body produces energy, makes neurotransmitters, repairs DNA, and manages stress. Without efficient methylation, your cells can’t produce ATP (cellular energy) efficiently.

Here’s the problem: the C677T variant, carried by roughly 40% of people with European ancestry, reduces this enzyme’s efficiency by 40 to 70%. Even if you eat a diet rich in B vitamins and supplementation looks good on paper, your cells are converting those vitamins into usable energy at a fraction of the rate they should be. You can be functionally depleted at the cellular level while your blood work looks completely normal.

You might feel persistent, unexplained fatigue that doesn’t improve with rest or more sleep. Your brain fog might not lift even when you optimize everything else. Your muscles might feel weak or achy. You might notice that standard B vitamin supplements don’t help, or that you need unusually high doses to feel any effect.

Your VDR gene produces a receptor that allows vitamin D to actually enter your cells and do its work. Vitamin D isn’t just about bone health. It controls mitochondrial biogenesis, the process by which your cells create new energy-producing structures. Without adequate vitamin D signaling at the cellular level, your mitochondria can’t produce ATP efficiently.

Common variants in VDR, found in roughly 30 to 50% of the population, reduce your cells’ sensitivity to vitamin D. You might have high blood levels of vitamin D but still not have adequate cellular uptake, meaning your mitochondria aren’t getting the signal to produce energy efficiently. This is a crucial gap: you can supplement vitamin D, see blood levels improve, and still feel exhausted because your cells aren’t actually receiving the signal.

You might feel relentless fatigue despite adequate sun exposure or supplementation. Your energy might tank predictably in winter or when you can’t get outside. You might feel weak or struggle with exercise recovery. You might notice that high-dose vitamin D supplementation doesn’t improve how you feel, even though your blood levels look good.

Your COMT gene produces an enzyme that clears dopamine, norepinephrine, and epinephrine from your nervous system. These are your stress and activation neurotransmitters. COMT is how your brain tells your nervous system to power down after stress has passed. It’s how you transition from alert to calm, and from wakefulness to sleep.

The Met158 slow variant, carried by roughly 25% of the population homozygously, impairs this clearance. Your nervous system stays activated longer than it should, even when the stress has passed, because you can’t clear these activation neurotransmitters efficiently. During sleep, this means your brain and nervous system never fully power down. You might sleep 8 hours but wake unrefreshed because your nervous system was never truly resting.

You might feel wired but tired, alert at night when you should be winding down, or unable to shift out of high-alert mode even hours after stress has passed. You might be sensitive to caffeine or stimulants, or find that they have an unusually prolonged effect. You might struggle to relax or have racing thoughts at bedtime. Your sleep might feel restless or non-restorative even when you log enough hours.

Your TCF7L2 gene regulates how your pancreas secretes insulin and how efficiently your cells take up glucose. It’s a master controller of blood sugar stability and metabolic health. When TCF7L2 is functioning optimally, your glucose stays steady, your energy is stable, and your metabolism runs efficiently.

Common variants in TCF7L2 increase your risk of glucose dysregulation and insulin resistance. You might have normal fasting glucose and normal A1C levels on blood work yet still struggle with energy crashes, cravings, and metabolic dysfunction because your glucose management is genetically less efficient. You can eat a balanced diet and still experience dramatic energy swings based on when and what you eat.

You might feel energy crashes mid-afternoon or within 2 hours of eating. You might crave carbohydrates or sugar, particularly when stressed or tired. You might struggle to lose weight despite eating well. You might notice that small amounts of certain foods dramatically affect your energy, while others have no effect. You might find that your energy and mental clarity are highly dependent on meal timing.

Your SLC6A4 gene produces a transporter that recycles serotonin after it’s been used. Serotonin is your mood and sleep neurotransmitter. Your brain reuses serotonin by pulling it back out of the synapse, which is much more efficient than making new serotonin constantly. When serotonin recycling works properly, you maintain stable mood, consistent energy, and good sleep quality.

The short allele variant of SLC6A4, carried by roughly 40% of people, impairs this recycling process. Your brain can’t recycle serotonin efficiently, leading to inconsistent serotonin availability and disrupted melatonin production, the hormone that initiates sleep. Your blood serotonin levels might look fine, but your brain’s local serotonin availability is compromised, particularly at night.

You might experience non-restorative sleep, waking unrefreshed despite sleeping long enough. You might have racing thoughts at bedtime or difficulty initiating sleep. You might notice mood variability that doesn’t match your circumstances. You might feel more anxious or depressed in winter. You might notice that your sleep quality is inconsistent, good some nights and terrible others, without an obvious pattern.

Your APOE gene produces apolipoprotein E, a protein that manages cholesterol transport in your brain and controls neuroinflammation. Your APOE type determines how vulnerable your brain is to aging, how efficiently you clear beta-amyloid (the protein implicated in Alzheimer’s), and how resilient your cognitive function is to stress, sleep deprivation, and metabolic dysfunction.

The APOE4 allele, carried by roughly 25% of the population, increases neuroinflammation and reduces amyloid clearance efficiency. If you carry APOE4, your brain is more vulnerable to cognitive decline, brain fog, and accelerated aging when you’re exposed to poor sleep, metabolic stress, or chronic inflammation. This doesn’t mean you will develop Alzheimer’s, but it does mean your brain requires more careful management of sleep, glucose stability, and inflammation.

You might notice cognitive decline that progresses faster than you’d expect, brain fog that worsens with poor sleep, or memory issues that appear earlier than they do in your peers. You might find that your cognition is highly sensitive to sleep quality, blood sugar stability, and stress. You might notice that standard preventive health measures don’t seem sufficient to keep your cognitive clarity stable.